These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3791256)

  • 1. Peak cerebrospinal fluid platinum levels in a patient with ependymoma: evaluation of two different methods of cisplatin administration.
    DeGregorio M; Wilbur B; King O; Wallenberg J; Prewitt S; Phillips J; Wilbur J
    Cancer Treat Rep; 1986 Dec; 70(12):1437-8. PubMed ID: 3791256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrafiltrate and total platinum in plasma and cerebrospinal fluid in a patient with neuroblastoma.
    DeGregorio MW; King OY; Holleran WM; Wilbur BJ; Cadman EC; Deisseroth AB; Wilbur JR
    Cancer Treat Rep; 1985 Dec; 69(12):1441-2. PubMed ID: 4075318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics of plasma and cerebrospinal fluid cisplatin in patients with malignant glioma and metastatic brain tumor after selective intraarterial or intravenous and intracarotid administration of etoposide and cisplatin].
    Nakagawa H; Miyawaki Y; Tokiyoshi K; Tsuruzono K; Yamada M; Kanayama T; Hayakawa T
    No Shinkei Geka; 1994 Jan; 22(1):35-42. PubMed ID: 8295700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.
    Lanvers-Kaminsky C; Krefeld B; Dinnesen AG; Deuster D; Seifert E; Würthwein G; Jaehde U; Pieck AC; Boos J
    Pediatr Blood Cancer; 2006 Aug; 47(2):183-93. PubMed ID: 16302218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin administered as a continuous 5-day infusion: plasma platinum levels and urine platinum excretion.
    Belliveau JF; Posner MR; Ferrari L; Crabtree GW; Cummings FJ; Wiemann MC; O'Leary GP; Griffin H; Phaneuf MA; O'Rourke A
    Cancer Treat Rep; 1986 Oct; 70(10):1215-7. PubMed ID: 3756943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of high-dose cisplatin administration (relationship between pharmacokinetics and administration schedule)].
    Yamamoto N; Yanagi K; Matuyama H; Shimizu K; Mitsui H; Shimabukuro T; Yamamoto M; Sakatoku J; Fujita T; Matsuoka K
    Hinyokika Kiyo; 1987 Nov; 33(11):1760-5. PubMed ID: 3445857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin.
    Meerum Terwogt JM; Groenewegen G; Pluim D; Maliepaard M; Tibben MM; Huisman A; ten Bokkel Huinink WW; Schot M; Welbank H; Voest EE; Beijnen JH; Schellens JM
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):201-10. PubMed ID: 11935212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates.
    Jacobs SS; Fox E; Dennie C; Morgan LB; McCully CL; Balis FM
    Clin Cancer Res; 2005 Feb; 11(4):1669-74. PubMed ID: 15746072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cis-diamminedichloroplatinum penetration into the cerebrospinal fluid of the lateral ventricle, postoperative cavity, and lumbar subarachnoid space with or without pre-intravenous mannitol administration in patients with brain metastasis from lung cancer].
    Nakagawa H; Yamada M; Tamura M; Yoshida M; Shindo M; Nishiyama H; Sakai S
    Gan To Kagaku Ryoho; 2014 Mar; 41(3):317-24. PubMed ID: 24743276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic study of Cis-dichlorodiammine platinum II, in children after rapid infusion.
    Cano JP; Catalin J; Rigault JP; Bues-Charbit M; Placidi M; Raybaud C; Bernard JL
    Biomedicine; 1981 Dec; 34(3):146-53. PubMed ID: 7199945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin nephrotoxicity. Correlation with plasma platinum concentrations.
    Kelsen DP; Alcock N; Young CW
    Am J Clin Oncol; 1985 Feb; 8(1):77-80. PubMed ID: 4039530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral methotrexate kinetics in a patient with intracranial anaplastic ependymoma.
    Geis T; Peters O; Friedrich M; Dränert E; Wolff JE
    Pediatr Blood Cancer; 2004 Jul; 43(1):78-80. PubMed ID: 15170895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin based chemotherapy in testicular cancer patients: long term platinum excretion and clinical effects.
    Hohnloser JH; Schierl R; Hasford B; Emmerich B
    Eur J Med Res; 1996 Sep; 1(11):509-14. PubMed ID: 9438151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cumulative pharmacokinetic study of oxaliplatin, administered every three weeks, combined with 5-fluorouracil in colorectal cancer patients.
    Gamelin E; Bouil AL; Boisdron-Celle M; Turcant A; Delva R; Cailleux A; Krikorian A; Brienza S; Cvitkovic E; Robert J; Larra F; Allain P
    Clin Cancer Res; 1997 Jun; 3(6):891-9. PubMed ID: 9815764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy.
    Veal GJ; Dias C; Price L; Parry A; Errington J; Hale J; Pearson AD; Boddy AV; Newell DR; Tilby MJ
    Clin Cancer Res; 2001 Aug; 7(8):2205-12. PubMed ID: 11489793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Superselective intra-arterial infusion chemotherapy of high-dose cisplatin for advanced paranasal sinus carcinomas].
    Yokoyama J; Shiga K; Saijo S; Matumoto K; Ogawa Y
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):967-73. PubMed ID: 10396325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma platinum levels: relationship to cisplatin dose and nephrotoxicity.
    Campbell AB; Kalman SM; Jacobs C
    Cancer Treat Rep; 1983 Feb; 67(2):169-72. PubMed ID: 6681731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
    Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T
    Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
    Bonetti A; Apostoli P; Zaninelli M; Pavanel F; Colombatti M; Cetto GL; Franceschi T; Sperotto L; Leone R
    Clin Cancer Res; 1996 Nov; 2(11):1829-35. PubMed ID: 9816137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetic study of intraperitoneal chemotherapy with high-dose cisplatin for advanced ovarian cancer].
    Deng C; Huang R; Lian L
    Zhonghua Fu Chan Ke Za Zhi; 1996 Mar; 31(3):159-62. PubMed ID: 8758790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.